<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0197882</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-40759</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Research reporting guidelines</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Agriculture</subject><subj-group><subject>Animal management</subject><subj-group><subject>Animal welfare</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Clinical research design</subject><subj-group><subject>Adverse events</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Agriculture</subject><subj-group><subject>Animal management</subject><subj-group><subject>Animal slaughter</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Scientific publishing</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Anesthetics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pain management</subject><subj-group><subject>Anesthetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Analgesics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pain management</subject><subj-group><subject>Analgesics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Economics</subject><subj-group><subject>Finance</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of <italic>in vivo</italic> Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia</article-title>
<alt-title alt-title-type="running-head">ARRIVE guidelines journal support outcome</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Leung</surname>
<given-names>Vivian</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Rousseau-Blass</surname>
<given-names>Frédérik</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Beauchamp</surname>
<given-names>Guy</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6420-477X</contrib-id>
<name name-style="western">
<surname>Pang</surname>
<given-names>Daniel S. J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Québec, Canada</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Pritchett-Corning</surname>
<given-names>Kathleen R.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Harvard University Faculty of Arts and Sciences, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">daniel.pang@umontreal.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>5</issue>
<elocation-id>e0197882</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Leung et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0197882"/>
<abstract>
<p>Poor research reporting is a major contributing factor to low study reproducibility, financial and animal waste. The ARRIVE (Animal Research: Reporting of <italic>In Vivo</italic> Experiments) guidelines were developed to improve reporting quality and many journals support these guidelines. The influence of this support is unknown. We hypothesized that papers published in journals supporting the ARRIVE guidelines would show improved reporting compared with those in non-supporting journals. In a retrospective, observational cohort study, papers from 5 ARRIVE supporting (SUPP) and 2 non-supporting (nonSUPP) journals, published before (2009) and 5 years after (2015) the ARRIVE guidelines, were selected. Adherence to the ARRIVE checklist of 20 items was independently evaluated by two reviewers and items assessed as fully, partially or not reported. Mean percentages of items reported were compared between journal types and years with an unequal variance t-test. Individual items and sub-items were compared with a chi-square test. From an initial cohort of 956, 236 papers were included: 120 from 2009 (SUPP; n = 52, nonSUPP; n = 68), 116 from 2015 (SUPP; n = 61, nonSUPP; n = 55). The percentage of fully reported items was similar between journal types in 2009 (SUPP: 55.3 ± 11.5% [SD]; nonSUPP: 51.8 ± 9.0%; p = 0.07, 95% CI of mean difference -0.3–7.3%) and 2015 (SUPP: 60.5 ± 11.2%; nonSUPP; 60.2 ± 10.0%; p = 0.89, 95%CI -3.6–4.2%). The small increase in fully reported items between years was similar for both journal types (p = 0.09, 95% CI -0.5–4.3%). No paper fully reported 100% of items on the ARRIVE checklist and measures associated with bias were poorly reported. These results suggest that journal support for the ARRIVE guidelines has not resulted in a meaningful improvement in reporting quality, contributing to ongoing waste in animal research.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000038</institution-id>
<institution>Natural Sciences and Engineering Research Council of Canada</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6420-477X</contrib-id>
<name name-style="western">
<surname>Pang</surname>
<given-names>Daniel SJ</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Fondation J.-Louis Lévesque</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6420-477X</contrib-id>
<name name-style="western">
<surname>Pang</surname>
<given-names>Daniel SJ</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>Natural Sciences and Engineering Research Council of Canada Discovery Grant awarded to DSJP (ID: 424022-2013) <ext-link ext-link-type="uri" xlink:href="http://www.nserc-crsng.gc.ca/index_eng.asp" xlink:type="simple">http://www.nserc-crsng.gc.ca/index_eng.asp</ext-link> Fondation J.-Louis Lévesque operating grant awarded to DSJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>The datasets generated during the current study are available from the Harvard Dataverse repository: Pang, Daniel, 2017, “ARRIVE guidelines study” doi:<ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7910/DVN/8IGTN3" xlink:type="simple">10.7910/DVN/8IGTN3</ext-link>, Harvard Dataverse, V1.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Accurate and complete reporting of animal experiments is central to supporting valid, reproducible research and to allow readers to critically evaluate published work. Poor or absent reporting is associated with deficiencies in experimental design that introduce bias and exaggerated effect sizes in to the literature [<xref ref-type="bibr" rid="pone.0197882.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0197882.ref002">2</xref>]. As a result, irreproducible animal research has significant ethical and financial costs [<xref ref-type="bibr" rid="pone.0197882.ref003">3</xref>]. The use of animals in poorly designed studies and in efforts to reproduce such studies represents a failure to uphold the 3Rs (refine, reduce, replace) of animal research [<xref ref-type="bibr" rid="pone.0197882.ref004">4</xref>]. Incomplete reporting of research contributes to a waste of funding, with a conservative estimate for preclinical research, of US$28 billion annually [<xref ref-type="bibr" rid="pone.0197882.ref003">3</xref>].</p>
<p>To address low standards of reporting, the ARRIVE (Animals in Research: Reporting <italic>In Vivo</italic> Experiments) guidelines for reporting were published in 2010 [<xref ref-type="bibr" rid="pone.0197882.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0197882.ref006">6</xref>]. The ARRIVE guidelines are summarized by a 20 item checklist that includes reporting of measures associated with bias (randomization, blinding, sample size calculation, data handling) [<xref ref-type="bibr" rid="pone.0197882.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0197882.ref008">8</xref>]. Over 1000 journals have responded to publication of the guidelines by linking to it on their websites and in their instructions to authors [<xref ref-type="bibr" rid="pone.0197882.ref009">9</xref>]. The effect of these endorsements is unknown. For the majority of existing health research guidelines, the impact of journal support for other reporting guidelines on guideline adherence in published papers is unclear [<xref ref-type="bibr" rid="pone.0197882.ref010">10</xref>]. The impact of the CONSORT guidelines for the reporting of randomised controlled trials have been evaluated more than other reporting guidelines, and current evidence suggests that though reporting of some items has improved, overall standards of reporting remain low [<xref ref-type="bibr" rid="pone.0197882.ref011">11</xref>].</p>
<p>To our knowledge, there have been no studies comparing reporting standards between journals classified as ARRIVE guideline supporters and non-supporters. Furthermore, no studies examining adherence to the ARRIVE guidelines have been conducted in the veterinary literature. We hypothesized that papers published in supporting journals would have greater adherence to the guidelines, and therefore higher reporting standards, than those published in non-supporting journals. Additionally, we hypothesized that papers published in supporting journals would show a greater improvement in reporting standards since the guidelines became available. To test these hypotheses the related subjects of anesthetic and analgesic efficacy and animal welfare were selected for study.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>Journal and paper selection</title>
<p>Journals were categorized as ARRIVE supporters (SUPP) or non-supporters (nonSUPP) based on whether the ARRIVE guidelines were mentioned in their instructions to authors when beginning the study (November 2016). Editorial offices of SUPP journals confirmed by email that the ARRIVE guidelines were included in the instructions to authors before December 2014. Papers were selected from a selection of journals from these two categories (SUPP and nonSUPP) from two years: 2009 (pre-ARRIVE) and 2015 (post-ARRIVE). SUPP journals were: Journal of the American Association for Laboratory Animal Science, Comparative Medicine, Animal Welfare, Laboratory Animals and Alternatives to Animal Experimentation. NonSUPP journals were: Applied Animal Behaviour Science and Experimental Animals. Journals were selected based on an initial search for those publishing papers on the predetermined subjects of interest (welfare, analgesic and anesthetic efficacy). Additionally, none of the selected journals had previously been included in a study assessing adherence to the ARRIVE guidelines.</p>
<p>An initial screening of all papers was performed by a single author (VL) by manual search of tables of contents, using titles, abstracts and keywords to identify relevant papers. Papers were selected based on subject and study type. A second screening was performed by two authors (VL and FRB) during the full text evaluation of the selected papers. Anesthesia or analgesia papers described studies assessing the efficacy of anesthetics or analgesics as a primary objective. Animal welfare papers described studies where the objective was to improve the well-being of animals used in research. Only prospective <italic>in vivo</italic> studies were included. Case studies were excluded.</p>
</sec>
<sec id="sec004">
<title>Evaluation</title>
<p>Evaluation of adherence to the ARRIVE guidelines was performed independently by two authors (VL and FRB). The ARRIVE checklist [<xref ref-type="bibr" rid="pone.0197882.ref006">6</xref>] of 20 items and 46 associated sub-items was operationalized and used as the basis for evaluation (<xref ref-type="table" rid="pone.0197882.t001">Table 1</xref>). Descriptors were developed by consensus to promote consistency during evaluation (<xref ref-type="table" rid="pone.0197882.t001">Table 1</xref>). Items without associated sub-items were categorized as either not reported, partially reported or fully reported. Items with sub-items were categorized as not reported if no sub-items were reported, partially reported if only some sub-items were reported and fully reported if all sub-items were reported. For example, for Item 6 (Study design, <xref ref-type="table" rid="pone.0197882.t001">Table 1</xref>), the item would only be classified as fully reported if all sub-items (6a-d) were reported, otherwise it would be classified as partially (3 or fewer sub-items reported) or not reported (none of the 4 sub-items reported).</p>
<table-wrap id="pone.0197882.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.t001</object-id>
<label>Table 1</label> <caption><title>The ARRIVE guidelines checklist: Operationalized items and sub-items to facilitate assessment of reporting [<xref ref-type="bibr" rid="pone.0197882.ref006">6</xref>].</title></caption>
<alternatives>
<graphic id="pone.0197882.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Item/sub-item</th>
<th align="left">ARRIVE items and sub-items</th>
<th align="left">Possible categories</th>
<th align="left">Descriptor</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">1</td>
<td align="left"><bold>Title</bold></td>
<td align="left"><bold>not reported; partially reported; fully reported</bold></td>
<td align="left">Accurate and concise description of article content</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left"><bold>Abstract</bold></td>
<td align="left"><bold>not reported; partially reported; fully reported</bold></td>
<td align="left">Accurate summary of background, research objectives, species or strain of animal used, key methods, principle findings, and conclusions</td>
</tr>
<tr>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6">Introduction</td>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6"/>
</tr>
<tr>
<td align="left">3</td>
<td align="left"><bold>Background</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">3a</td>
<td align="left">Motivation for and context of study</td>
<td align="left">not reported; reported</td>
<td align="left">Sufficient scientific background (with references) on motivation and context of study, with explanation of experimental approach and rationale</td>
</tr>
<tr>
<td align="left">3b</td>
<td align="left">Animal species and models justified</td>
<td align="left">not reported; reported</td>
<td align="left">Explain how and why animal species and models were chosen</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left"><bold>Objectives</bold></td>
<td align="left"><bold>not reported; partially reported; fully reported</bold></td>
<td align="left">Objectives or hypotheses of study are clearly described</td>
</tr>
<tr>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6">Methods</td>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6"/>
</tr>
<tr>
<td align="left">5</td>
<td align="left"><bold>Ethical Statement</bold></td>
<td align="left"><bold>not reported; fully reported</bold></td>
<td align="left">Statement to indicate ethical review permissions, relevant licenses and national or institutional guidelines for care and use of animals</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">6a</td>
<td align="left">Number of groups</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Number of experimental and control groups clearly stated; N/A if single group study</td>
</tr>
<tr>
<td align="left">6b</td>
<td align="left">Randomization</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that randomization was used or justification for no randomization; N/A if single group study</td>
</tr>
<tr>
<td align="left">6c</td>
<td align="left">Blinding</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that blinding was used or justification for no blinding; N/A if single group study. Classified as “reported” if blinding was mentioned for any step (e.g. blinding to allocation, blinding to outcome assessment, treatment administration etc.).</td>
</tr>
<tr>
<td align="left">6d</td>
<td align="left">Experimental unit</td>
<td align="left">not reported; reported</td>
<td align="left">Reader is able to understand if comparisons were between a single animal or a group of animals</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left"><bold>Experimental procedures</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">7a</td>
<td align="left">How</td>
<td align="left">not reported; reported</td>
<td align="left">Description of experiment performed and details of specialised equipment used can be replicated with the information present</td>
</tr>
<tr>
<td align="left">7b</td>
<td align="left">When</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of when during the day the procedures took place and when according to the experimental timeline; N/A if paper was assessing continuous assessment or if light cycle unlikely to affect assessment (e.g. lameness)</td>
</tr>
<tr>
<td align="left">7c</td>
<td align="left">Where</td>
<td align="left">not reported; reported</td>
<td align="left">Some indication of where each procedure took place</td>
</tr>
<tr>
<td align="left">7d</td>
<td align="left">Why</td>
<td align="left">not reported; reported</td>
<td align="left">Rationale for why chosen experimental procedures were performed</td>
</tr>
<tr>
<td align="left">7e</td>
<td align="left">Drugs used</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of the name, dose, route, and frequency of the analgesics or anesthetics used; N/A if procedures can be obviously performed without analgesic or anesthetics</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left"><bold>Experimental animals</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">8a</td>
<td align="left">Species</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of species used</td>
</tr>
<tr>
<td align="left">8b</td>
<td align="left">Strain</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of strain used</td>
</tr>
<tr>
<td align="left">8c</td>
<td align="left">Sex</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of sex used</td>
</tr>
<tr>
<td align="left">8d</td>
<td align="left">Developmental stage</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of age of animals used</td>
</tr>
<tr>
<td align="left">8e</td>
<td align="left">Weight</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of the animals’ weight; N/A for zoo animals</td>
</tr>
<tr>
<td align="left">8f</td>
<td align="left">Source</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of animals’ source; N/A for zoo animals</td>
</tr>
<tr>
<td align="left">8g</td>
<td align="left">Health/immune status</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of animals’ heath (i.e. screening of tested animals or sentinel animals for lab animals) or general statement that animals were healthy for farm, companion, and zoo animals</td>
</tr>
<tr>
<td align="left">9</td>
<td align="left"><bold>Housing and husbandry</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">9a</td>
<td align="left">Type of cage/housing</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of cage dimensions and product source for lab animals and a general description for companion and zoo animals; N/A if paper was on animals being process for slaughter (e.g. study at abattoir)</td>
</tr>
<tr>
<td align="left">9b</td>
<td align="left">Bedding material</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of bedding type and source for lab animals and a general description for non-lab animals; N/A for fish species or animals being processed for slaughter</td>
</tr>
<tr>
<td align="left">9c</td>
<td align="left">Type of facility</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of facility type and a general description for non-lab animal; N/A if paper was on animals being process for slaughter</td>
</tr>
<tr>
<td align="left">9d</td>
<td align="left">Number of cage companions</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of number of animals housed together or individually; N/A if paper was on animals being processed for slaughter</td>
</tr>
<tr>
<td align="left">9e</td>
<td align="left">Light/dark cycle</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of time lights were on/off for lab animals; information of place of facility and time of experiment is accepted as an alternative for farm and zoo animals<xref ref-type="table-fn" rid="t001fn002">*</xref>; N/A if paper was on animals being process for slaughter</td>
</tr>
<tr>
<td align="left">9f</td>
<td align="left">Temperature</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of temperature animals were housed in; information of place of facility and time of experiment is acceptable as an alternative for farm and zoo animals<xref ref-type="table-fn" rid="t001fn002">*</xref>; N/A if paper was on animals being process for slaughter</td>
</tr>
<tr>
<td align="left">9g</td>
<td align="left">Type of food</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of food type and sources for lab animals; general description (e.g. hay for cattle) acceptable for non-lab animals; N/A if paper was on animals being process for slaughter</td>
</tr>
<tr>
<td align="left">9h</td>
<td align="left">Water access</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that water was provided; N/A for fish species or animals being processed for slaughter</td>
</tr>
<tr>
<td align="left">9i</td>
<td align="left">Environmental enrichment</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that a form of enrichment was provided; N/A if paper was on animals being processed for slaughter</td>
</tr>
<tr>
<td align="left">9j</td>
<td align="left">Humidity</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of humidity for lab animals; information of place and time of experiments is acceptable as an alternative for farm and zoo animals<xref ref-type="table-fn" rid="t001fn002">*</xref>; N/A for fish species or animals being processed for slaughter</td>
</tr>
<tr>
<td align="left">9k</td>
<td align="left">Welfare assessment</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that a form of welfare assessment was in place; point was awarded by default if the paper was a welfare paper; N/A if the intervention performed was not for the benefit of the animals involved</td>
</tr>
<tr>
<td align="left">9l</td>
<td align="left">Welfare interventions</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of what type of welfare intervention prepared; intervention must be in response to animals’ well-being and not from an outcome of the experiment e.g. Eye issues from eye procedure vs. Weight loss; N/A if no adverse event is expected (i.e. animal assessed after death)</td>
</tr>
<tr>
<td align="left">9m</td>
<td align="left">Time of welfare assessment or intervention</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of when welfare assessment or intervention occurred; N/A if no adverse event expected (e.g. study was assessing a new enrichment)</td>
</tr>
<tr>
<td align="left">10</td>
<td align="left"><bold>Sample size</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">10a</td>
<td align="left">Total number of animals used</td>
<td align="left">not reported; reported</td>
<td align="left">Statement specifying in absolute numbers of the total number of animals used in each experiment and treatment groups</td>
</tr>
<tr>
<td align="left">10b</td>
<td align="left">Sample size calculation</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement that sample size calculation was performed; N/A if pilot study</td>
</tr>
<tr>
<td align="left">10c</td>
<td align="left">Number of independent replications<xref ref-type="table-fn" rid="t001fn003">**</xref></td>
<td align="left">reported; N/A</td>
<td align="left">Statement of the number of independent replications performed</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left"><bold>Allocating animals</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">11a</td>
<td align="left">Allocation method</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement of how animals were allocated to groups, including randomization or matching if done; N/A if single treatment group</td>
</tr>
<tr>
<td align="left">11b</td>
<td align="left">Treatment and assessment of animals</td>
<td align="left">not reported; reported</td>
<td align="left">Describe the order in which the animals in the different experimental groups were treated and assessed</td>
</tr>
<tr>
<td align="left">12</td>
<td align="left"><bold>Experimental outcomes</bold></td>
<td align="left"><bold>not reported; partially reported; fully reported</bold></td>
<td align="left">Define the primary and secondary experimental outcomes assessed</td>
</tr>
<tr>
<td align="left">13</td>
<td align="left"><bold>Statistical methods</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">13a</td>
<td align="left">Details of statistical methods used</td>
<td align="left">not reported; reported</td>
<td align="left">Statistical tests performed for each analysis was clear</td>
</tr>
<tr>
<td align="left">13b</td>
<td align="left">Specify unit of analysis</td>
<td align="left">not reported; reported</td>
<td align="left">Unit of analysis was clear for each data set</td>
</tr>
<tr>
<td align="left">13c</td>
<td align="left">Assess normality</td>
<td align="left">not reported; reported</td>
<td align="left">Statement that assessment of normality was performed</td>
</tr>
<tr>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6">Results</td>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6"/>
</tr>
<tr>
<td align="left">14</td>
<td align="left"><bold>Baseline data</bold></td>
<td align="left"><bold>not reported; fully reported</bold></td>
<td align="left">Statement to report relevant characteristics and health status of animals were collected</td>
</tr>
<tr>
<td align="left">15</td>
<td align="left"><bold>Numbers analysed</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">15a</td>
<td align="left">Animals included</td>
<td align="left">not reported; reported</td>
<td align="left">Statement of the number of animals included/excluded in absolute numbers</td>
</tr>
<tr>
<td align="left">15b</td>
<td align="left">Reasons for animal exclusion</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Statement detailing why animals were excluded; N/A if no animals excluded</td>
</tr>
<tr>
<td align="left">16</td>
<td align="left"><bold>Outcomes and estimation</bold></td>
<td align="left"><bold>not reported; partially reported; fully reported</bold></td>
<td align="left">Results for each analysis was clear with a measure of precision (e.g. standard error or confidence interval)</td>
</tr>
<tr>
<td align="left">17</td>
<td align="left"><bold>Adverse events</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">17a</td>
<td align="left">Details of adverse events</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Reported details of adverse events that occurred or a statement to report no adverse events occurred; N/A if no adverse events expected</td>
</tr>
<tr>
<td align="left">17b</td>
<td align="left">Modifications to reduce adverse events</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Modifications to experimental procedures made to reduce adverse events were described; N/A if no adverse event expected</td>
</tr>
<tr>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6">Discussion</td>
<td align="left" style="background-color:#E7E6E6"/>
<td align="left" style="background-color:#E7E6E6"/>
</tr>
<tr>
<td align="left">18</td>
<td align="left"><bold>Interpretation/scientific implications</bold></td>
<td align="left"><bold>depends on sub-items</bold></td>
<td align="left"><bold>-</bold></td>
</tr>
<tr>
<td align="left">18a</td>
<td align="left">Interpretation</td>
<td align="left">not reported; reported</td>
<td align="left">Interpret results, taking into account study objectives and hypotheses, current theory and other relevant studies in literature</td>
</tr>
<tr>
<td align="left">18b</td>
<td align="left">Study limitations</td>
<td align="left">not reported; reported</td>
<td align="left">Commented on the study limitations including potential sources of bias, any limitations of the animal model and the imprecision associated with results</td>
</tr>
<tr>
<td align="left">18c</td>
<td align="left">Implications for 3Rs of animal use</td>
<td align="left">not reported; reported; N/A</td>
<td align="left">Described any implications of experimental methods or findings for the replacement, refinement or reduction (3Rs) of the use of animals in research; point was awarded if it was a welfare paper; N/A if assessing anatomic response to an analgesic or anesthetic (e.g. buprenorphine effects on limb volume)</td>
</tr>
<tr>
<td align="left">19</td>
<td align="left"><bold>Generalizability/translation</bold></td>
<td align="left"><bold>not reported; fully reported; N/A</bold></td>
<td align="left">Commented on whether the findings of this study are likely to translate to other species or systems, including any relevance to human biology; N/A for welfare paper unless specified in discussion</td>
</tr>
<tr>
<td align="left">20</td>
<td align="left"><bold>Funding</bold></td>
<td align="left"><bold>not reported; fully reported</bold></td>
<td align="left">List all funding sources and the role of the funder(s) in the study</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Items are bolded and listed with a number. Sub-items are listed with a number and letter.</p></fn>
<fn id="t001fn002"><p>*Acceptable to report only place and time of year for 9e) light/dark cycle; 9f) temperature; 9j) humidity as this information can be inferred if animals (production and zoo types) are housed outdoors</p></fn>
<fn id="t001fn003"><p>** Number of independent replications was scored as not applicable (N/A) when not reported as this sub-item was not required for a complete study.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>A sub-item was added to the original ARRIVE checklist to clarify drug use (sub-item 7e, <xref ref-type="table" rid="pone.0197882.t001">Table 1</xref>). Where items or sub-items were considered not applicable, no score was entered. For example, a paper on zebra fish would have the sub-items bedding materials, access to water and humidity classed as not applicable.</p>
<p>Item and sub-item scores were compared between authors and differences resolved by consensus (with DP).</p>
</sec>
<sec id="sec005">
<title>Statistics</title>
<p>Each paper was assessed against the 20 items of the ARRIVE guidelines, generating percentages of fully reported items. From this, mean percentages of items were calculated for each journal type during each publication year. Following Levene’s test revealing heterogeneity of variances, an unequal variance t-test was used to compare these mean percentages between journal types (SUPP 2009 vs nonSUPP 2009; SUPP 2015 vs nonSUPP 2015) and between years (SUPP 2009 vs. SUPP 2015; nonSUPP 2009 vs. nonSUPP 2015). Correction for multiple comparisons was not applied as comparisons between identical items were viewed as independent from other items. The overall quality of item reporting was classified as well (&gt; 80%), average (50–80%) or poor (&lt; 50%) [<xref ref-type="bibr" rid="pone.0197882.ref012">12</xref>]. For each journal type, the percentages of individual items and sub-items that were fully, partially or not reported were compared between years with a chi-square test. Additionally, to provide an overall impression of reporting standards in 2015 data from both journal types were pooled.</p>
</sec>
</sec>
<sec id="sec006" sec-type="results">
<title>Results</title>
<p>After initial screening, 271 papers were identified. Thirty-five papers were excluded following full text evaluation, leaving 236 papers included in the final analysis (SUPP 2009: n = 52; SUPP 2015: n = 61; nonSUPP 2009: n = 68; nonSUPP 2015: n = 55, <xref ref-type="fig" rid="pone.0197882.g001">Fig 1</xref>). One item and one sub item (generalizability/translation (item 19), number of independent replication (sub- item 10c)) were removed before analysis as they were only applicable in a small number of papers (4/236 and 10/236, respectively). Data are available from the Harvard dataverse [<xref ref-type="bibr" rid="pone.0197882.ref013">13</xref>].</p>
<fig id="pone.0197882.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of paper selection process.</title>
<p>Papers were selected from studies reporting research in anesthesia, analgesia and animal welfare from 5 veterinary journals.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.g001" xlink:type="simple"/>
</fig>
<p>The percentages of fully reported items between journal types were similar in 2009 (p = 0.07) and 2015 (p = 0.89; <xref ref-type="table" rid="pone.0197882.t002">Table 2</xref>). The percentage of fully reported items increased significantly from 2009 to 2015 for both SUPP (p = 0.02) and nonSUPP (p = 0.0001; <xref ref-type="table" rid="pone.0197882.t002">Table 2</xref>) journals. Although both journal types showed improvements from 2009 to 2015, neither improved significantly more than the other (absolute difference in change between nonSUPP–SUPP = 3.3%, p = 0.09 [95% CI -0.5–4.3%]).</p>
<table-wrap id="pone.0197882.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.t002</object-id>
<label>Table 2</label> <caption><title>Overall reporting quality in journals supporting (SUPP) and not supporting (nonSUPP) the ARRIVE guidelines for 2009 and 2015.</title></caption>
<alternatives>
<graphic id="pone.0197882.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="right">2009 (%)</th>
<th align="right">2015 (%)</th>
<th align="right"><xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref>p-value [95% CI]</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">SUPP</td>
<td align="right">55.3 ± 11.5</td>
<td align="right">60.5 ± 11.2</td>
<td align="right">0.02 [1.0–9.4]</td>
</tr>
<tr>
<td align="left">Non-SUPP</td>
<td align="right">51.8 ± 9.0</td>
<td align="right">60.2 ± 10.0</td>
<td align="right">0.0001 [5.0–11.8]</td>
</tr>
<tr>
<td align="left"><xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref>p value [95% CI]</td>
<td align="right">0.07 [-0.3–7.3]</td>
<td align="right">0.89 [-3.6–4.2]</td>
<td align="right"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Values are mean percentages of fully reported items. The numbers of papers examined were: SUPP 2009; n = 52, SUPP 2015; n = 61, nonSUPP 2009; n = 68, nonSUPP 2015; n = 55.</p></fn>
<fn id="t002fn002"><p><sup>a</sup>p values of differences between journal types within the same year.</p></fn>
<fn id="t002fn003"><p><sup>b</sup>p-values of differences between years for the same journal type. 95% confidence interval (95% CI) is for the mean difference.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="sec007">
<title>Items</title>
<p>Despite minimal improvements in overall reporting standards between 2009 and 2015, several individual items showed significant improvement in full reporting. For SUPP journals, these items were the abstract (from 69.2 to 91.8%, p = 0.003), housing and husbandry (from 3.9 to 21.3%, p = 0.01) and sample size (from 3.8 to 21.3%, p = 0.01; <xref ref-type="table" rid="pone.0197882.t003">Table 3</xref>). For nonSUPP journals, the following items were increasingly fully reported from 2009 to 2015: ethical statement (from 36.8 to 81.8%, p &lt; 0.0001); experimental animals (from 1.5 to 10.9%, p = 0.04) and interpretation/scientific implications (from 10.3 to 38.2%, p = 0.0004; <xref ref-type="table" rid="pone.0197882.t003">Table 3</xref>).</p>
<table-wrap id="pone.0197882.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.t003</object-id>
<label>Table 3</label> <caption><title>Papers fully reporting ARRIVE checklist items in supporting (SUPP) and non-supporting (nonSUPP) journals in 2009 and 2015.</title></caption>
<alternatives>
<graphic id="pone.0197882.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2" style="background-color:#FFFFFF">Item</th>
<th align="right" colspan="3" style="background-color:#FFFFFF">SUPP</th>
<th align="right" colspan="3" style="background-color:#FFFFFF">NonSUPP</th>
</tr>
<tr>
<th align="left" style="background-color:#FFFFFF"/>
<th align="left" style="background-color:#FFFFFF"/>
<th align="center" style="background-color:#FFFFFF">2009 (N = 52)</th>
<th align="right" style="background-color:#FFFFFF">2015 (N = 61)</th>
<th align="right" style="background-color:#FFFFFF"/>
<th align="right" style="background-color:#FFFFFF">2009 (N = 68)</th>
<th align="right" style="background-color:#FFFFFF">2015 (N = 55)</th>
<th align="right" style="background-color:#FFFFFF"/>
</tr>
<tr>
<th align="left" style="background-color:#FFFFFF"/>
<th align="left" style="background-color:#FFFFFF"/>
<th align="center" style="background-color:#FFFFFF">n/N (% reported)</th>
<th align="right" style="background-color:#FFFFFF">n/N (% reported)</th>
<th align="right" style="background-color:#FFFFFF">p-value</th>
<th align="right" style="background-color:#FFFFFF">n/N (% reported)</th>
<th align="right" style="background-color:#FFFFFF">n/N (% reported)</th>
<th align="right" style="background-color:#FFFFFF">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#FFFFFF">1</td>
<td align="left" style="background-color:#FFFFFF">Title</td>
<td align="right" style="background-color:#FFFFFF">52/52 (100)</td>
<td align="right" style="background-color:#FFFFFF">61/61 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
<td align="right" style="background-color:#FFFFFF">68/68 (100)</td>
<td align="right" style="background-color:#FFFFFF">55/55 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">2</td>
<td align="left" style="background-color:#FFFFFF">Abstract</td>
<td align="right" style="background-color:#FFFFFF">36/52 (69.2)</td>
<td align="right" style="background-color:#FFFFFF">56/61 (91.8)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.003</bold></td>
<td align="right" style="background-color:#FFFFFF">45/68 (66.2)</td>
<td align="right" style="background-color:#FFFFFF">44/55 (80.0)</td>
<td align="right" style="background-color:#FFFFFF">0.11</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">3</td>
<td align="left" style="background-color:#FFFFFF">Background</td>
<td align="right" style="background-color:#FFFFFF">52/52 (100)</td>
<td align="right" style="background-color:#FFFFFF">60/61 (98.4)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
<td align="right" style="background-color:#FFFFFF">68/68 (100)</td>
<td align="right" style="background-color:#FFFFFF">55/55 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">4</td>
<td align="left" style="background-color:#FFFFFF">Objectives</td>
<td align="right" style="background-color:#FFFFFF">47/52 (90.2)</td>
<td align="right" style="background-color:#FFFFFF">60/61 (98.4)</td>
<td align="right" style="background-color:#FFFFFF">0.09</td>
<td align="right" style="background-color:#FFFFFF">68/68 (100)</td>
<td align="right" style="background-color:#FFFFFF">55/55 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">5</td>
<td align="left" style="background-color:#FFFFFF">Ethical statement</td>
<td align="right" style="background-color:#FFFFFF">39/52 (75.0)</td>
<td align="right" style="background-color:#FFFFFF">52/61 (85.2)</td>
<td align="right" style="background-color:#FFFFFF">0.23</td>
<td align="right" style="background-color:#FFFFFF">25/68 (36.8)</td>
<td align="right" style="background-color:#FFFFFF">45/55 (81.8)</td>
<td align="right" style="background-color:#FFFFFF"><bold>&lt;0.0001</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">6</td>
<td align="left" style="background-color:#FFFFFF">Study design</td>
<td align="right" style="background-color:#FFFFFF">10/52 (19.2)</td>
<td align="right" style="background-color:#FFFFFF">19/61 (31.1)</td>
<td align="right" style="background-color:#FFFFFF">0.20</td>
<td align="right" style="background-color:#FFFFFF">10/68 (14.7)</td>
<td align="right" style="background-color:#FFFFFF">15/55 (27.3)</td>
<td align="right" style="background-color:#FFFFFF">0.12</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">7</td>
<td align="left" style="background-color:#FFFFFF">Experimental procedure</td>
<td align="right" style="background-color:#FFFFFF">34/52 (65.4)</td>
<td align="right" style="background-color:#FFFFFF">30/61 (49.2)</td>
<td align="right" style="background-color:#FFFFFF">0.09</td>
<td align="right" style="background-color:#FFFFFF">45/68 (66.2)</td>
<td align="right" style="background-color:#FFFFFF">42/55 (76.4)</td>
<td align="right" style="background-color:#FFFFFF">0.24</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">8</td>
<td align="left" style="background-color:#FFFFFF">Experimental animals</td>
<td align="right" style="background-color:#FFFFFF">8/52 (15.4)</td>
<td align="right" style="background-color:#FFFFFF">18/61 (29.5)</td>
<td align="right" style="background-color:#FFFFFF">0.12</td>
<td align="right" style="background-color:#FFFFFF">1/68 (1.5)</td>
<td align="right" style="background-color:#FFFFFF">6/55 (10.9)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.04</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">9</td>
<td align="left" style="background-color:#FFFFFF">Housing and husbandry</td>
<td align="right" style="background-color:#FFFFFF">2/51 (3.9)</td>
<td align="right" style="background-color:#FFFFFF">13/61 (21.3)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.01</bold></td>
<td align="right" style="background-color:#FFFFFF">3/67 (4.5)</td>
<td align="right" style="background-color:#FFFFFF">8/54 (14.8)</td>
<td align="right" style="background-color:#FFFFFF">0.06</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">10</td>
<td align="left" style="background-color:#FFFFFF">Sample size</td>
<td align="right" style="background-color:#FFFFFF">2/52 (3.8)</td>
<td align="right" style="background-color:#FFFFFF">13/61 (21.3)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.01</bold></td>
<td align="right" style="background-color:#FFFFFF">1/68 (1.5)</td>
<td align="right" style="background-color:#FFFFFF">3/55 (5.5)</td>
<td align="right" style="background-color:#FFFFFF">0.32</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">11</td>
<td align="left" style="background-color:#FFFFFF">Allocating animals</td>
<td align="right" style="background-color:#FFFFFF">11/52 (21.2)</td>
<td align="right" style="background-color:#FFFFFF">16/61 (26.2)</td>
<td align="right" style="background-color:#FFFFFF">0.66</td>
<td align="right" style="background-color:#FFFFFF">14/68 (20.6)</td>
<td align="right" style="background-color:#FFFFFF">17/55 (30.9)</td>
<td align="right" style="background-color:#FFFFFF">0.22</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">12</td>
<td align="left" style="background-color:#FFFFFF">Experimental outcomes</td>
<td align="right" style="background-color:#FFFFFF">52/52 (100)</td>
<td align="right" style="background-color:#FFFFFF">61/61 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
<td align="right" style="background-color:#FFFFFF">66/67 (98.5)</td>
<td align="right" style="background-color:#FFFFFF">55/55 (100)</td>
<td align="right" style="background-color:#FFFFFF">1</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">13</td>
<td align="left" style="background-color:#FFFFFF">Statistical methods</td>
<td align="right" style="background-color:#FFFFFF">23/52 (44.2)</td>
<td align="right" style="background-color:#FFFFFF">29/61 (47.5)</td>
<td align="right" style="background-color:#FFFFFF">0.85</td>
<td align="right" style="background-color:#FFFFFF">38/68 (55.9)</td>
<td align="right" style="background-color:#FFFFFF">32/55 (58.2)</td>
<td align="right" style="background-color:#FFFFFF">0.86</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">14</td>
<td align="left" style="background-color:#FFFFFF">Baseline data</td>
<td align="right" style="background-color:#FFFFFF">24/41 (58.5)</td>
<td align="right" style="background-color:#FFFFFF">27/50 (54.0)</td>
<td align="right" style="background-color:#FFFFFF">0.68</td>
<td align="right" style="background-color:#FFFFFF">20/30 (66.7)</td>
<td align="right" style="background-color:#FFFFFF">18/35 (51.4)</td>
<td align="right" style="background-color:#FFFFFF">0.31</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">15</td>
<td align="left" style="background-color:#FFFFFF">Numbers analysed</td>
<td align="right" style="background-color:#FFFFFF">29/52 (55.8)</td>
<td align="right" style="background-color:#FFFFFF">39/61 (63.9)</td>
<td align="right" style="background-color:#FFFFFF">0.44</td>
<td align="right" style="background-color:#FFFFFF">37/68 (54.4)</td>
<td align="right" style="background-color:#FFFFFF">25/55 (45.5)</td>
<td align="right" style="background-color:#FFFFFF">0.37</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">16</td>
<td align="left" style="background-color:#FFFFFF">Outcomes and estimation</td>
<td align="right" style="background-color:#FFFFFF">45/52 (86.5)</td>
<td align="right" style="background-color:#FFFFFF">49/61 (80.3)</td>
<td align="right" style="background-color:#FFFFFF">0.45</td>
<td align="right" style="background-color:#FFFFFF">55/68 (80.9)</td>
<td align="right" style="background-color:#FFFFFF">49/55 (89.1)</td>
<td align="right" style="background-color:#FFFFFF">0.32</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">17</td>
<td align="left" style="background-color:#FFFFFF">Adverse events</td>
<td align="right" style="background-color:#FFFFFF">18/29 (62.1)</td>
<td align="right" style="background-color:#FFFFFF">17/41 (41.5)</td>
<td align="right" style="background-color:#FFFFFF">0.15</td>
<td align="right" style="background-color:#FFFFFF">4/18 (22.2)</td>
<td align="right" style="background-color:#FFFFFF">8/23 (34.8)</td>
<td align="right" style="background-color:#FFFFFF">0.50</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">17a</td>
<td align="left" style="background-color:#FFFFFF">Details of adverse events</td>
<td align="right" style="background-color:#FFFFFF">25/29 (86.2)</td>
<td align="right" style="background-color:#FFFFFF">25/41 (61.0)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.03</bold></td>
<td align="right" style="background-color:#FFFFFF">8/18 (44.4)</td>
<td align="right" style="background-color:#FFFFFF">20/24 (83.3)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.02</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">18</td>
<td align="left" style="background-color:#FFFFFF">Interpretation/scientific implications</td>
<td align="right" style="background-color:#FFFFFF">15/52 (28.8)</td>
<td align="right" style="background-color:#FFFFFF">20/61 (32.8)</td>
<td align="right" style="background-color:#FFFFFF">0.69</td>
<td align="right" style="background-color:#FFFFFF">7/68 (10.3)</td>
<td align="right" style="background-color:#FFFFFF">21/55 (38.2)</td>
<td align="right" style="background-color:#FFFFFF"><bold>0.0004</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">19</td>
<td align="left" style="background-color:#FFFFFF">Generalisability/translation</td>
<td align="right" style="background-color:#FFFFFF">-</td>
<td align="right" style="background-color:#FFFFFF">-</td>
<td align="right" style="background-color:#FFFFFF">-</td>
<td align="right" style="background-color:#FFFFFF">-</td>
<td align="right" style="background-color:#FFFFFF">-</td>
<td align="right" style="background-color:#FFFFFF">-</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">20</td>
<td align="left" style="background-color:#FFFFFF">Funding</td>
<td align="right" style="background-color:#FFFFFF">29/52 (55.8)</td>
<td align="right" style="background-color:#FFFFFF">43/61 (70.5)</td>
<td align="right" style="background-color:#FFFFFF">0.12</td>
<td align="right" style="background-color:#FFFFFF">48/68 (70.6)</td>
<td align="right" style="background-color:#FFFFFF">44/55 (80)</td>
<td align="right" style="background-color:#FFFFFF">0.30</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>N = total number of papers where the item was applicable. n = total number of papers reporting the item. p values are for comparisons between years for each journal type.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In SUPP journals, sample size was reported at least partially by all papers in 2009 but was not reported in 9.8% of papers in 2015 (p = 0.03, <xref ref-type="supplementary-material" rid="pone.0197882.s001">S1 Table</xref> and <xref ref-type="table" rid="pone.0197882.t003">Table 3</xref>). In both SUPP and nonSUPP journals, items that were frequently not reported in both 2009 and 2015 were baseline data, numbers analyzed and funding.</p>
<p>Pooling the percentage of fully reported items in 2015 from both journal types revealed that items with excellent (&gt; 80%), average (50–80%) and poor (&lt; 50%) reporting was distributed in to thirds (<xref ref-type="fig" rid="pone.0197882.g002">Fig 2</xref>). Title, abstract, background, objectives, ethical statement, experimental outcomes, and outcomes and estimation were well reported. In contrast, ethical statement, baseline data, numbers analyzed, adverse events and funding were poorly reported.</p>
<fig id="pone.0197882.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Bar graph of papers fully reporting individual items from the ARRIVE checklist.</title>
<p>Data from papers published in 2015 were pooled from ARRIVE supporting (SUPP, n = 61 papers) and non-supporting (nonSUPP, n = 55 papers) journals. Broken horizontal lines indicate reporting quality thresholds: excellent (&gt; 80%), average (50–80%) and poor (&lt; 50%) [<xref ref-type="bibr" rid="pone.0197882.ref012">12</xref>].</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec008">
<title>Sub-items</title>
<p>There were significant improvements in percentages of papers reporting a small number of sub-items between years for each journal type though overall levels of reporting remained low (<xref ref-type="supplementary-material" rid="pone.0197882.s002">S2 Table</xref>). Notably amongst these were sub-items associated with bias: blinding (sub-item 6c), sample size calculation (sub-item 10b), allocation method (sub-item 11a) and data handling (sub-item 15b) (<xref ref-type="fig" rid="pone.0197882.g003">Fig 3</xref>) Randomization (sub-item 6b) was alone in being reported more than 50% of the time (<xref ref-type="fig" rid="pone.0197882.g003">Fig 3</xref>).</p>
<fig id="pone.0197882.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0197882.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Radar plot of ARRIVE checklist sub-items associated with bias reported in ARRIVE supporting (SUPP) and non-supporting (nonSUPP) journals in 2015.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.g003" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec009" sec-type="conclusions">
<title>Discussion</title>
<p>Numerous studies across different research fields have shown that reporting quality has remained low since the publication of the ARRIVE guidelines [<xref ref-type="bibr" rid="pone.0197882.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0197882.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0197882.ref018">18</xref>]. This is in spite of large scale support for the guidelines by biomedical journals and increasing awareness of the financial and ethical cost of irreproducible research [<xref ref-type="bibr" rid="pone.0197882.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0197882.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0197882.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0197882.ref019">19</xref>]. The results of our study confirm that reporting quality remains low and that journal support for the ARRIVE guidelines has not resulted in meaningful improvements in reporting standards.</p>
<sec id="sec010">
<title>Adherence to reporting guidelines remains low despite journal support</title>
<p>Reporting standards in this sample of anesthesia, analgesia and animal welfare papers was low, with little indication that the ARRIVE guidelines have made an impact in improving reporting standards. These findings echo those of others [<xref ref-type="bibr" rid="pone.0197882.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0197882.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0197882.ref016">16</xref>]. The data presented here, published 5 years after introduction of the ARRIVE guidelines, reflect the low reporting rates identified by Kilkenny et al. (2009) [<xref ref-type="bibr" rid="pone.0197882.ref005">5</xref>] that served as the catalyst for creation of the guidelines. As in those findings, reporting of important indicators of study design quality (randomization, blinding, sample size calculation and data handling) remain low.</p>
<p>A recent study of the veterinary literature that focused on reporting of randomization in randomised controlled trials found a higher percentage pf papers (49%, n = 106) reporting the allocation method than reported here (13–20% for SUPP and nonSUPP, respectively) [<xref ref-type="bibr" rid="pone.0197882.ref020">20</xref>]. This difference is likely to have resulted from selecting papers self-describing as randomised clinical trials.</p>
<p>With the small observed increase in reported items in both SUPP and nonSUPP journals, an increased awareness of reporting standards, such as the ARRIVE guidelines, cannot be ruled out. However, these increases were limited, with no significant differences in fully reported items between journal types in 2015 and, perhaps most importantly, the reporting of key sub-items indicating bias (randomization; sub-items 6b and 11a, blinding; sub-item 6c, animals excluded; sub-item 15b and sample size calculation; sub-item 10b) remained low [<xref ref-type="bibr" rid="pone.0197882.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0197882.ref008">8</xref>]. Similar findings have been reported in surveys of experimental animal models, including acute lung injury, peri-odontology, autoimmunity and neoplasia [<xref ref-type="bibr" rid="pone.0197882.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0197882.ref018">18</xref>]. Sample size justification, in particular, is consistently poorly reported, with reporting percentages ranging from 0–7% [<xref ref-type="bibr" rid="pone.0197882.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0197882.ref018">18</xref>]. This is an alarming figure given the impact it has on interpretation of findings and animal use [<xref ref-type="bibr" rid="pone.0197882.ref021">21</xref>].</p>
<p>A common feature in this and other studies of ARRIVE guideline adherence has been a lack of enforcement of reporting standards. In contrast, when reporting is mandatory, important improvements have been achieved [<xref ref-type="bibr" rid="pone.0197882.ref022">22</xref>, <xref ref-type="bibr" rid="pone.0197882.ref023">23</xref>]. Following a change in editorial policy in 2013, the Nature research journals now require that authors accompany accepted manuscripts with a completed checklist identifying inclusion of key items associated with quality of reporting and study design [<xref ref-type="bibr" rid="pone.0197882.ref024">24</xref>]. This checklist has numerous items in common with those of the ARRIVE guidelines. In reviewing approximately 440 papers in each of two groups (those published in the Nature publishing journals and those from other publishers, before and after checklist implementation), the positive effect of the checklist was evident in that reporting of bias criteria (randomization, blinding, sample size calculation and data handling) [<xref ref-type="bibr" rid="pone.0197882.ref007">7</xref>] improved significantly from 0 to 16.4% [<xref ref-type="bibr" rid="pone.0197882.ref023">23</xref>]. While this number remains low, the percentage of papers from other publishers reporting these items was &lt; 1% over the same time period. In striking contrast with the findings presented here and elsewhere [<xref ref-type="bibr" rid="pone.0197882.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0197882.ref018">18</xref>], introduction of the checklist was associated with a mention of sample size calculation in 58% (90/154) of papers, increasing from &lt; 2% (3/192).</p>
</sec>
<sec id="sec011">
<title>Suggestions to improved guideline adherence</title>
<p>To date, a change in editorial policy accompanied by mandatory submission of a reporting checklist is the only method shown to have resulted in an increase in reporting quality [<xref ref-type="bibr" rid="pone.0197882.ref023">23</xref>]. This clearly indicates that enforcement is required to generate a change in behavior. As others have suggested, achieving change in a well-established process, such as peer-review, is difficult [<xref ref-type="bibr" rid="pone.0197882.ref025">25</xref>]. Furthermore, placing the responsibility of policing guideline adherence on reviewers is unrealistic, when they are volunteering their time, usually busy and may share the same view of an unenforced request to complete a checklist [<xref ref-type="bibr" rid="pone.0197882.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0197882.ref025">25</xref>].</p>
<p>Other, albeit untested, suggestions to improve reporting standards include: 1. using a template of the methods section to require completion of desired items [<xref ref-type="bibr" rid="pone.0197882.ref025">25</xref>], 2. standardizing reporting of common outcomes by learned societies and research communities [<xref ref-type="bibr" rid="pone.0197882.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0197882.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0197882.ref029">29</xref>] and 3. mandating adherence to reporting standards at the stage of applying for federal authority to conduct research (in countries where this applies), perhaps in the form of study registration [<xref ref-type="bibr" rid="pone.0197882.ref030">30</xref>]. These suggestions, along with the checklist used by the Nature research journals, represent a shift away from the current format of the ARRIVE guidelines towards a shorter checklist. Irrespective of scope and format, it is clear reporting standards will remain low without some form of enforced adherence [<xref ref-type="bibr" rid="pone.0197882.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0197882.ref025">25</xref>]. An important consequence of enforced compliance, which must be considered when selecting a method to improve reporting, is the associated cost (time and financial resources) to publishers and authors, and striking an acceptable balance between an ideal and that which is feasible, practical and achievable.</p>
</sec>
<sec id="sec012">
<title>Limitations</title>
<p>Our data may have been skewed by the small number of journals in the nonSUPP group and any policies of individual journals on how compliance with the ARRIVE reporting guidelines were assessed. The choice of journals was limited due to the large number that have registered support for the ARRIVE guidelines and our choice of subject matter. While this reflects the success of the ARRIVE guidelines in being widely adopted, our data highlight that the relationship between guideline support and adherence merits investigation [<xref ref-type="bibr" rid="pone.0197882.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0197882.ref031">31</xref>]. Despite the low number of journals included, the risk of systematic journal bias is likely to be low given similar standards of reporting have been documented across a wide range of biomedical journals [<xref ref-type="bibr" rid="pone.0197882.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0197882.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0197882.ref018">18</xref>].</p>
</sec>
<sec id="sec013">
<title>Conclusion</title>
<p>Journal support for the ARRIVE guidelines has not resulted in improved reporting standards, with the lowest levels of reporting associated with factors reflecting potential study bias. To achieve meaningful improvements in reporting standards, as a means to improve study reproducibility and reduce financial and animal waste, enforcement of reporting is necessary.</p>
</sec>
</sec>
<sec id="sec014">
<title>Supporting information</title>
<supplementary-material id="pone.0197882.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Papers partially reporting ARRIVE checklist items in supporting (SUPP) and non-supporting (nonSUPP) journals in 2009 and 2015.</title>
<p>N = total number of papers where the item was applicable. n = total number of papers partially reporting the item. p values are for comparisons between years for each journal type.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0197882.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0197882.s002" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Papers fully reporting ARRIVE checklist sub-items in supporting (SUPP) and non-supporting (nonSUPP) journals in 2009 and 2015.</title>
<p>N = total number of journal articles where the sub-item was applicable; n = total number of journal articles reporting the sub-item. p values are for comparisons between years for each journal type.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Dr Michael E Mullins (Washington University School of Medicine) for inspiring the title of this paper.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0197882.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macleod</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>van der Worp</surname> <given-names>HB</given-names></name>, <name name-style="western"><surname>Sena</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Howells</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Dirnagl</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Donnan</surname> <given-names>GA</given-names></name>. <article-title>Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>: <fpage>2824</fpage>–<lpage>2829</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.108.515957" xlink:type="simple">10.1161/STROKEAHA.108.515957</ext-link></comment> <object-id pub-id-type="pmid">18635842</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vesterinen</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Sena</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>ffrench-Constant</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chandran</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Macleod</surname> <given-names>MR</given-names></name>. <article-title>Improving the translational hit of experimental treatments in multiple sclerosis</article-title>. <source>Mult Scler</source>. <year>2010</year>;<volume>16</volume>: <fpage>1044</fpage>–<lpage>1055</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1352458510379612" xlink:type="simple">10.1177/1352458510379612</ext-link></comment> <object-id pub-id-type="pmid">20685763</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freedman</surname> <given-names>LP</given-names></name>, <name name-style="western"><surname>Cockburn</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Simcoe</surname> <given-names>TS</given-names></name>. <article-title>The Economics of Reproducibility in Preclinical Research</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>: <fpage>e1002165</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1002165" xlink:type="simple">10.1371/journal.pbio.1002165</ext-link></comment> <object-id pub-id-type="pmid">26057340</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref004"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Russell WMS, Burch RL. The Principles of Humane Experimental Technique. 1992 Available from: <ext-link ext-link-type="uri" xlink:href="http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc" xlink:type="simple">http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc</ext-link></mixed-citation></ref>
<ref id="pone.0197882.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kilkenny</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Parsons</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kadyszewski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Festing</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Cuthill</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Fry</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Survey of the quality of experimental design, statistical analysis and reporting of research using animals</article-title>. <source>PLoS One</source>. <year>2009</year>;<volume>4</volume>: <fpage>e7824</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0007824" xlink:type="simple">10.1371/journal.pone.0007824</ext-link></comment> <object-id pub-id-type="pmid">19956596</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kilkenny</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Browne</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Cuthill</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Emerson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</article-title>. <source>PLoS Biol</source>. <year>2010</year>;<volume>8</volume>: <fpage>e1000412</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1000412" xlink:type="simple">10.1371/journal.pbio.1000412</ext-link></comment> <object-id pub-id-type="pmid">20613859</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Amara</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Asadullah</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Blumenstein</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bradley</surname> <given-names>EW</given-names></name>, <etal>et al</etal>. <article-title>A call for transparent reporting to optimize the predictive value of preclinical research</article-title>. <source>Nature</source>. <year>2012</year>;<volume>490</volume>: <fpage>187</fpage>–<lpage>191</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature11556" xlink:type="simple">10.1038/nature11556</ext-link></comment> <object-id pub-id-type="pmid">23060188</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macleod</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Lawson McLean</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kyriakopoulou</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Serghiou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>de Wilde</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sherratt</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Risk of Bias in Reports of In Vivo Research: A Focus for Improvement</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>: <fpage>e1002273</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1002273" xlink:type="simple">10.1371/journal.pbio.1002273</ext-link></comment> <object-id pub-id-type="pmid">26460723</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref009"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Anon. ARRIVE: Animal Research Reporting In Vivo Experiments. National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nc3rs.org.uk/arrive-animal-research-reporting-vivo-experiments" xlink:type="simple">https://www.nc3rs.org.uk/arrive-animal-research-reporting-vivo-experiments</ext-link></mixed-citation></ref>
<ref id="pone.0197882.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stevens</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shamseer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Weinstein</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yazdi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Thielman</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>: <fpage>g3804</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.g3804" xlink:type="simple">10.1136/bmj.g3804</ext-link></comment> <object-id pub-id-type="pmid">24965222</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shamseer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Weeks</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Peters</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kober</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2012</year>;<volume>11</volume>: MR000030.</mixed-citation></ref>
<ref id="pone.0197882.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Delgado-Ruiz</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Calvo-Guirado</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Romanos</surname> <given-names>GE</given-names></name>. <article-title>Critical size defects for bone regeneration experiments in rabbit calvariae: systematic review and quality evaluation using ARRIVE guidelines</article-title>. <source>Clin Oral Implants Res</source>. <year>2015</year>;<volume>26</volume>: <fpage>915</fpage>–<lpage>930</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/clr.12406" xlink:type="simple">10.1111/clr.12406</ext-link></comment> <object-id pub-id-type="pmid">24766503</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref013"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Leung V, Rousseau-Blass F, Pang DSJ. “ARRIVE guidelines study”. 2017 Database: Harvard dataverse [Internet]. Available from: Pang, Daniel, 2017, “ARRIVE guidelines study”, <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/8IGTN3" xlink:type="simple">10.7910/DVN/8IGTN3</ext-link></comment>, Harvard Dataverse, V1</mixed-citation></ref>
<ref id="pone.0197882.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Avey</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sullivan</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Fergusson</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Griffin</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Grimshaw</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0166733</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0166733" xlink:type="simple">10.1371/journal.pone.0166733</ext-link></comment> <object-id pub-id-type="pmid">27855228</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baker</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Lidster</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sottomayor</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Amor</surname> <given-names>S</given-names></name>. <article-title>Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies</article-title>. <source>PLoS Biol</source>. <year>2014</year>;<volume>12</volume>: <fpage>e1001756</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1001756" xlink:type="simple">10.1371/journal.pbio.1001756</ext-link></comment> <object-id pub-id-type="pmid">24409096</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Mai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Adherence to ARRIVE Guidelines in Chinese Journal Reports on Neoplasms in Animals</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0154657</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0154657" xlink:type="simple">10.1371/journal.pone.0154657</ext-link></comment> <object-id pub-id-type="pmid">27182788</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwarz</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Iglhaut</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>J</given-names></name>. <article-title>Quality assessment of reporting of animal studies on pathogenesis and treatment of peri-implant mucositis and peri-implantitis. A systematic review using the ARRIVE guidelines</article-title>. <source>J Clin Periodontol</source>. <year>2012</year>;<volume>39</volume> <issue>Suppl 12</issue>: <fpage>63</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="pone.0197882.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ting</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Hill</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Whittle</surname> <given-names>SL</given-names></name>. <article-title>Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines</article-title>. <source>Int J Rheum Dis</source>. <year>2015</year>;<volume>18</volume>: <fpage>488</fpage>–<lpage>494</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1756-185X.12699" xlink:type="simple">10.1111/1756-185X.12699</ext-link></comment> <object-id pub-id-type="pmid">26082348</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ioannidis</surname> <given-names>JP</given-names></name>. <article-title>Why most published research findings are false</article-title>. <source>PLoS Med</source>. <year>2005</year>;<volume>2</volume>: <fpage>e124</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.0020124" xlink:type="simple">10.1371/journal.pmed.0020124</ext-link></comment> <object-id pub-id-type="pmid">16060722</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Girolamo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Giuffrida</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Meursinge Reynders</surname> <given-names>R</given-names></name>. <article-title>In veterinary trials reporting and communication regarding randomisation procedures is suboptimal</article-title>. <source>Vet Rec</source>. <year>2017</year>;<volume>181</volume>: <fpage>195</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/vr.104035" xlink:type="simple">10.1136/vr.104035</ext-link></comment> <object-id pub-id-type="pmid">28487452</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Button</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Ioannidis</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Mokrysz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Nosek</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Flint</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>ES</given-names></name>, <etal>et al</etal>. <article-title>Power failure: why small sample size undermines the reliability of neuroscience</article-title>. <source>Nat Rev Neurosci</source>. <year>2013</year>;<volume>14</volume>: <fpage>365</fpage>–<lpage>376</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrn3475" xlink:type="simple">10.1038/nrn3475</ext-link></comment> <object-id pub-id-type="pmid">23571845</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Olonisakin</surname> <given-names>TF</given-names></name>, <name name-style="western"><surname>Pribis</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Zupetic</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yoon</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Holleran</surname> <given-names>KM</given-names></name>, <etal>et al</etal>. <article-title>A checklist is associated with increased quality of reporting preclinical biomedical research: A systematic review</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>: <fpage>e0183591</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0183591" xlink:type="simple">10.1371/journal.pone.0183591</ext-link></comment> <object-id pub-id-type="pmid">28902887</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macleod</surname> <given-names>MR</given-names></name>, <collab>group TNPQIPC</collab>. <article-title>Findings of a retrospective, controlled cohort study of the impact of a change in Nature journals’ editorial policy for life sciences research on the completeness of reporting study design and execution</article-title>. <source>bioRxiv</source>. 2017187245.</mixed-citation></ref>
<ref id="pone.0197882.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple">Anon. <article-title>Reducing our irreproducibility</article-title>. <source>Nature</source>. <year>2013</year>;<volume>496</volume>: <fpage>398</fpage>.</mixed-citation></ref>
<ref id="pone.0197882.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGrath</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Lilley</surname> <given-names>E</given-names></name>. <article-title>Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP</article-title>. <source>Br J Pharmacol</source>. <year>2015</year>;<volume>172</volume>: <fpage>3189</fpage>–<lpage>3193</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bph.12955" xlink:type="simple">10.1111/bph.12955</ext-link></comment> <object-id pub-id-type="pmid">25964986</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baker</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Amor</surname> <given-names>S</given-names></name>. <article-title>Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis</article-title>. <source>J Neuroimmunol</source>. <year>2012</year>;<volume>242</volume>: <fpage>78</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jneuroim.2011.11.003" xlink:type="simple">10.1016/j.jneuroim.2011.11.003</ext-link></comment> <object-id pub-id-type="pmid">22119102</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fisher</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Feuerstein</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Howells</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Hurn</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Kent</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Savitz</surname> <given-names>SI</given-names></name>, <etal>et al</etal>. <article-title>Update of the stroke therapy academic industry roundtable preclinical recommendations</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>: <fpage>2244</fpage>–<lpage>2250</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.108.541128" xlink:type="simple">10.1161/STROKEAHA.108.541128</ext-link></comment> <object-id pub-id-type="pmid">19246690</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ludolph</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Bendotti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Blaugrund</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Chio</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Greensmith</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Loeffler</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for preclinical animal research in ALS/MND: A consensus meeting</article-title>. <source>Amyotroph Lateral Scler</source>. <year>2010</year>;<volume>11</volume>: <fpage>38</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/17482960903545334" xlink:type="simple">10.3109/17482960903545334</ext-link></comment> <object-id pub-id-type="pmid">20184514</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shineman</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Basi</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Bizon</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Colton</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Hollister</surname> <given-names>BA</given-names></name>, <etal>et al</etal>. <article-title>Accelerating drug discovery for Alzheimer’s disease: best practices for preclinical animal studies</article-title>. <source>Alzheimers Res Ther</source>. <year>2011</year>;<volume>3</volume>: <fpage>28</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/alzrt90" xlink:type="simple">10.1186/alzrt90</ext-link></comment> <object-id pub-id-type="pmid">21943025</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vogt</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Reichlin</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Nathues</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Würbel</surname> <given-names>H</given-names></name>. <article-title>Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor</article-title>. <source>PLoS Biol</source>. <year>2016</year>;<volume>14</volume>: <fpage>e2000598</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.2000598" xlink:type="simple">10.1371/journal.pbio.2000598</ext-link></comment> <object-id pub-id-type="pmid">27911892</object-id></mixed-citation></ref>
<ref id="pone.0197882.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cressey</surname> <given-names>D</given-names></name>. <article-title>Surge in support of animal-research guidelines</article-title>. <source>Nature</source> <year>2016</year> <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature.2016.19274" xlink:type="simple">10.1038/nature.2016.19274</ext-link></comment></mixed-citation></ref>
</ref-list>
</back>
</article>